cancer
Conditions
Interventions
Observation group:none
Sponsors
Jiangnan University Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Male or female; 2. Age >=18 years at the time of signing the informed consent; 3. Clinically and pathologically confirmed malignant tumor (solid tumor and/or hematologic tumor); 4. Clinical judgment that the use of targeted anti-tumor drugs can benefit the patient, and the patient has received at least one dose of molecular targeted therapy; 5. Able to undergo long-term follow-up; 6. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Mental abnormalities or speech disorders preventing cooperation with examination or follow-up; 2. Other severe diseases with an expected life expectancy of less than 1 month; 3. Other situations that the researcher deems necessary to exclude.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events after medication use; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease progression;Adverse reaction outcome;The direct or indirect medical costs resulting from the occurrence of AE; | — |
Countries
China
Contacts
Public ContactYongjuan Ding
Jiangnan University Affiliated Hospital
Outcome results
None listed